- Home
- HHS vs BRNS Comparison
HHS vs BRNS Comparison
Compare HHS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.34
HOLD
Current Price
$0.73
Company Overview
Basic Information| Metric | HHS | BRNS |
|---|---|---|
| Founded | 1923 | 2016 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.9M | 55.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | HHS | BRNS |
|---|---|---|
| Price | $3.34 | $0.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 9.1K | ★ 69.3K |
| Earning Date | 11-10-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $166,841,000.00 | N/A |
| Revenue This Year | $6.54 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1766.46 |
| 52 Week Low | $2.33 | $0.64 |
| 52 Week High | $5.59 | $2.92 |
Technical Indicators
Market Signals| Indicator | HHS | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 52.02 | 38.31 |
| Support Level | $3.04 | $0.68 |
| Resistance Level | $3.35 | $0.74 |
| Average True Range (ATR) | 0.14 | 0.05 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 75.38 | 31.64 |
Price Performance
Historical Comparison HHS
BRNS
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.